TienYu Owen Yang
Research Subjects
TienYu Owen Yang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Mei-Huei Chen
Institute of Population Health Sciences, Taiwan National Health Research Institutes, No. 35, Keyan Road, Zhunan Township, Miaoli County, 350, Taiwan; Department of Pediatrics, National Taiwan University College of Medicine and Hospital, No. 1, Section 1, Ren'ai Road, Zhongzheng District, Taipei City, 100, Taiwan
5 shared publications- Wan-Ting Huang
Global Health Program, College of Public Health, National Taiwan University, Taipei City, 10055, Taiwan.
5 shared publications Kuan-Ying Arthur Huang
Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Guishan District, Taoyuan City, 333, Taiwan
4 shared publications- Benjamin J. Cairns
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
3 shared publications Gillian K. Reeves
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
3 shared publicationsJane Green
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
3 shared publications
Latest Publications
- Open Access
- 17 July 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (12) , 2477-2487
Prospective associations of diabetes with 15 cancers in 2.2 million UK and Chinese adults
Background: Diabetes has been associated with the risk of numerous cancers, but the causal relevance of many of these associations remains unclear. Methods: We investigated associations between diabetes and risks of 15 cancers using Cox-regression and individual-level data from 2.2 million adults (334 978 incident cancer cases) in 3 prospective cohorts, UK Biobank, Million Women Study, and China Kadoorie Biobank. The potential impact of residual confounding was assessed by examining changes in diabetes-associated log hazard ratios (HRs) after adjustment for key confounders. Results: In combined analyses of individual participant data from 3 studies, diabetes was positively associated with the risk of 11 cancers, most notably liver (HR = 2.04, 95% CI = 1.87 to 2.23), pancreas (HR = 1.62, 95% CI = 1.48 to 1.77), and bladder (HR = 1.44, 95% CI = 1.29 to 1.62) cancer. The positive associations of diabetes with cancers of the breast, endometrium, kidney, and esophageal adenocarcinoma were substantially attenuated (>50%) after adjustment for confounders. The risks were similar in UK and Chinese populations except for liver cancer for which the adjusted hazard ratio was greater in UK than Chinese adults (HR = 2.58, 95% CI = 2.28 to 2.92, vs HR = 1.61, 95% CI = 1.43 to 1.83; Phet = 2.5 x 10−6). For liver cancer, the excess risk associated with diabetes increased with increasing body mass index (Ptrend = 2.7 x 10−4) and alcohol intake (Ptrend = .02). Diabetes was inversely associated with incidence of prostate cancer (HR = 0.78, 95% CI = 0.73 to 0.85) but positively associated with mortality (HR = 1.25, 95% CI = 1.00 to 1.55). Conclusions: Diabetes increases the risk of liver, pancreatic, and bladder cancer in UK and Chinese populations. It may also have a lesser effect on stomach, colorectal cancer, and leukemia, but its associations with other cancers could well be explained by confounding and/or other biases.
- 17 July 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (12) , 2477-2487
Open AccessProspective associations of diabetes with 15 cancers in 2.2 million UK and Chinese adults
Background: Diabetes has been associated with the risk of numerous cancers, but the causal relevance of many of these associations remains unclear. Methods: We investigated associations between diabetes and risks of 15 cancers using Cox-regression and individual-level data from 2.2 million adults (334 978 incident cancer cases) in 3 prospective cohorts, UK Biobank, Million Women Study, and China Kadoorie Biobank. The potential impact of residual confounding was assessed by examining changes in diabetes-associated log hazard ratios (HRs) after adjustment for key confounders. Results: In combined analyses of individual participant data from 3 studies, diabetes was positively associated with the risk of 11 cancers, most notably liver (HR = 2.04, 95% CI = 1.87 to 2.23), pancreas (HR = 1.62, 95% CI = 1.48 to 1.77), and bladder (HR = 1.44, 95% CI = 1.29 to 1.62) cancer. The positive associations of diabetes with cancers of the breast, endometrium, kidney, and esophageal adenocarcinoma were substantially attenuated (>50%) after adjustment for confounders. The risks were similar in UK and Chinese populations except for liver cancer for which the adjusted hazard ratio was greater in UK than Chinese adults (HR = 2.58, 95% CI = 2.28 to 2.92, vs HR = 1.61, 95% CI = 1.43 to 1.83; Phet = 2.5 x 10−6). For liver cancer, the excess risk associated with diabetes increased with increasing body mass index (Ptrend = 2.7 x 10−4) and alcohol intake (Ptrend = .02). Diabetes was inversely associated with incidence of prostate cancer (HR = 0.78, 95% CI = 0.73 to 0.85) but positively associated with mortality (HR = 1.25, 95% CI = 1.00 to 1.55). Conclusions: Diabetes increases the risk of liver, pancreatic, and bladder cancer in UK and Chinese populations. It may also have a lesser effect on stomach, colorectal cancer, and leukemia, but its associations with other cancers could well be explained by confounding and/or other biases.
- 13 October 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (6)
Response: Rheumatoid arthritis and cancer risk in the Million Women Study
- 13 October 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (6)
Response: Rheumatoid arthritis and cancer risk in the Million Women Study
- Open Access
- 1 September 2024
- Published by Wiley
not-yet-known not-yet-known not-yet-known unknown Prevalence, Trends, and Accessibility in Prescription Practices: Prescribing in Taiwan
Not-yet-known not-yet-known not-yet-known unknown Purpose The prevalence and time trend of prescription practices provide context to pharmacoepidemiological studies. This study aims to present accessible information on prescription practices over time within Taiwan’s healthcare system to aid healthcare professionals, policymakers, and researchers. Methods Data were sourced from the Taiwan National Health Insurance Research Databases, compiling prescribing rates for specific ATC (Anatomical Therapeutic Chemical) drug groups stratified by age and sex for the years 2005, 2010, 2015, and 2020. Information on drug doses, durations, subtypes, brands, co-prescribed medications, and co-occurring diagnoses was not included. Results The dataset includes 400 ATC drug groups and over 19,822 data points. Analysis reveals diverse prescribing trends, such as the increased prescribing rates for statins from 2005 to 2020, especially among individuals in their 60s and 70s. Significant fluctuations in drug utilization patterns were observed, which may reflect broader health trends and policy impacts over the periods examined. Conclusion The ”Prescribing in Taiwan” data resource serves as a valuable tool to improve research efficiency and transparency by providing preliminary data access and reducing barriers for researchers. Enhancements to include more detailed data could further support pharmacoepidemiological research and healthcare decision-making.
- 1 September 2024
- Published by Wiley
Open Accessnot-yet-known not-yet-known not-yet-known unknown Prevalence, Trends, and Accessibility in Prescription Practices: Prescribing in Taiwan
Not-yet-known not-yet-known not-yet-known unknown Purpose The prevalence and time trend of prescription practices provide context to pharmacoepidemiological studies. This study aims to present accessible information on prescription practices over time within Taiwan’s healthcare system to aid healthcare professionals, policymakers, and researchers. Methods Data were sourced from the Taiwan National Health Insurance Research Databases, compiling prescribing rates for specific ATC (Anatomical Therapeutic Chemical) drug groups stratified by age and sex for the years 2005, 2010, 2015, and 2020. Information on drug doses, durations, subtypes, brands, co-prescribed medications, and co-occurring diagnoses was not included. Results The dataset includes 400 ATC drug groups and over 19,822 data points. Analysis reveals diverse prescribing trends, such as the increased prescribing rates for statins from 2005 to 2020, especially among individuals in their 60s and 70s. Significant fluctuations in drug utilization patterns were observed, which may reflect broader health trends and policy impacts over the periods examined. Conclusion The ”Prescribing in Taiwan” data resource serves as a valuable tool to improve research efficiency and transparency by providing preliminary data access and reducing barriers for researchers. Enhancements to include more detailed data could further support pharmacoepidemiological research and healthcare decision-making.
- Open Access
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Rheumatoid arthritis and cancer risk in the Million Women Study
Background: Most previous studies of rheumatoid arthritis (RA) and cancer risk have lacked information on potential confounding factors. We investigated RA-associated cancer risks in a large cohort of women in the UK, taking account of shared risk factors. Methods: In 1996–2001, women aged 50–64, who were invited for routine breast screening at 66 National Health Service (NHS) screening centres in England and Scotland, were also invited to take part in the Million Women Study. Participants provided information on sociodemographic, lifestyle and health-related factors, including RA, and were followed up for cancers and deaths. Cox regression yielded RA-associated hazard ratios (HRs) of 20 cancers, adjusted for 10 characteristics including smoking status and adiposity. Results: Around 1.3 million women (half of those invited) were recruited into the study. In minimally adjusted analyses, RA was associated with the risk of 13 of the 20 cancers. After additional adjustment for lifestyle factors, many of these associations were attenuated but there remained robust evidence of RA-associated increases in the risk of lung (HR 1.21, 95% confidence interval 1.15–1.26), lymphoid (1.25, 1.18–1.33), myeloid (1.12, 1.01–1.25), cervical (1.39, 1.11–1.75) and oropharyngeal (1.40, 1.21–1.61) cancers, and decreases in the risk of endometrial (0.84, 0.77–0.91) and colorectal (0.82, 0.77–0.87) cancers. Conclusions: After taking account of shared risk factors, RA is positively associated with lung and certain blood and infection-related cancers, and inversely associated with colorectal cancer. These findings are consistent with existing hypotheses around immune response, susceptibility to infections, and chronic inflammation. The inverse association observed for endometrial cancer merits further investigation.
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Open AccessRheumatoid arthritis and cancer risk in the Million Women Study
Background: Most previous studies of rheumatoid arthritis (RA) and cancer risk have lacked information on potential confounding factors. We investigated RA-associated cancer risks in a large cohort of women in the UK, taking account of shared risk factors. Methods: In 1996–2001, women aged 50–64, who were invited for routine breast screening at 66 National Health Service (NHS) screening centres in England and Scotland, were also invited to take part in the Million Women Study. Participants provided information on sociodemographic, lifestyle and health-related factors, including RA, and were followed up for cancers and deaths. Cox regression yielded RA-associated hazard ratios (HRs) of 20 cancers, adjusted for 10 characteristics including smoking status and adiposity. Results: Around 1.3 million women (half of those invited) were recruited into the study. In minimally adjusted analyses, RA was associated with the risk of 13 of the 20 cancers. After additional adjustment for lifestyle factors, many of these associations were attenuated but there remained robust evidence of RA-associated increases in the risk of lung (HR 1.21, 95% confidence interval 1.15–1.26), lymphoid (1.25, 1.18–1.33), myeloid (1.12, 1.01–1.25), cervical (1.39, 1.11–1.75) and oropharyngeal (1.40, 1.21–1.61) cancers, and decreases in the risk of endometrial (0.84, 0.77–0.91) and colorectal (0.82, 0.77–0.87) cancers. Conclusions: After taking account of shared risk factors, RA is positively associated with lung and certain blood and infection-related cancers, and inversely associated with colorectal cancer. These findings are consistent with existing hypotheses around immune response, susceptibility to infections, and chronic inflammation. The inverse association observed for endometrial cancer merits further investigation.
- Open Access
- 8 March 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-9
Body size in early life and the risk of postmenopausal breast cancer
Background: Greater early life adiposity has been reported to reduce postmenopausal breast cancer risk but it is unclear whether this association varies by tumour characteristics. We aimed to assess associations of early life body size with postmenopausal breast cancer and its subtypes, allowing for body size at other ages. Methods: A total of 342,079 postmenopausal UK women who reported their body size at age 10, clothes size at age 20, and body mass index (BMI) at baseline (around age 60) were followed by record linkage to national databases for cancers and deaths. Cox regression yielded adjusted relative risks (RRs) of breast cancer, overall and by tumour subtype, in relation to body size at different ages. Results: During an average follow-up of 14 years, 15,506 breast cancers were diagnosed. After adjustment for 15 potential confounders, greater BMI at age 60 was associated with an increased risk of postmenopausal breast cancer (RR per 5 kg/m2=1.20, 95%CI 1.18-1.22) whereas greater adiposity in childhood and, to a lesser extent, early adulthood, was associated with a reduced risk (0.70, 0.66-0.74, and 0.92, 0.89-0.96, respectively). Additional adjustment for midlife BMI strengthened associations with BMI at both age 10 (0.63, 0.60-0.68) and at age 20 (0.78, 0.75-0.81). The association with midlife adiposity was confined to hormone sensitive subtypes but early life adiposity had a similar impact on the risk of all subtypes. Conclusion: Early life and midlife adiposity have opposite effects on postmenopausal breast cancer risk and the biological mechanisms underlying these associations are likely to differ.
- 8 March 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-9
Open AccessBody size in early life and the risk of postmenopausal breast cancer
Background: Greater early life adiposity has been reported to reduce postmenopausal breast cancer risk but it is unclear whether this association varies by tumour characteristics. We aimed to assess associations of early life body size with postmenopausal breast cancer and its subtypes, allowing for body size at other ages. Methods: A total of 342,079 postmenopausal UK women who reported their body size at age 10, clothes size at age 20, and body mass index (BMI) at baseline (around age 60) were followed by record linkage to national databases for cancers and deaths. Cox regression yielded adjusted relative risks (RRs) of breast cancer, overall and by tumour subtype, in relation to body size at different ages. Results: During an average follow-up of 14 years, 15,506 breast cancers were diagnosed. After adjustment for 15 potential confounders, greater BMI at age 60 was associated with an increased risk of postmenopausal breast cancer (RR per 5 kg/m2=1.20, 95%CI 1.18-1.22) whereas greater adiposity in childhood and, to a lesser extent, early adulthood, was associated with a reduced risk (0.70, 0.66-0.74, and 0.92, 0.89-0.96, respectively). Additional adjustment for midlife BMI strengthened associations with BMI at both age 10 (0.63, 0.60-0.68) and at age 20 (0.78, 0.75-0.81). The association with midlife adiposity was confined to hormone sensitive subtypes but early life adiposity had a similar impact on the risk of all subtypes. Conclusion: Early life and midlife adiposity have opposite effects on postmenopausal breast cancer risk and the biological mechanisms underlying these associations are likely to differ.
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (9) , 1749-1757
Urban-rural differences in the prevalence and correlates of mild cognitive impairment in community-dwelling older adults in Taiwan: The EMCIT study
- 1 September 2021
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (9) , 1749-1757
Open AccessUrban-rural differences in the prevalence and correlates of mild cognitive impairment in community-dwelling older adults in Taiwan: The EMCIT study
- 1 August 2020
- Published by Elsevier in Cancer Epidemiology
- Vol. 67, 101767
Time-dependent associations between presentation-based infections and subsequent risk of childhood immune cell malignancies
- 1 August 2020
- Published by Elsevier in Cancer Epidemiology
- Vol. 67, 101767
Time-dependent associations between presentation-based infections and subsequent risk of childhood immune cell malignancies
- Open Access
- 11 June 2019
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 34 (9) , 863-870
Adult cancer risk in women who were breastfed as infants: large UK prospective study
There are known short-term benefits in breastfed infants versus bottle-fed infants in terms of lower risks of infection and obesity in infancy and childhood, but the long-term effect on the risk of adult cancers is unclear. In a cohort of 1 in 4 UK women born in 1935–1950 we report the incidence of adult cancers in relation to having been breastfed in infancy. In median year 2001 (interquartile range 2000–2003) 548,741 women without prior cancer reported whether they had been breastfed. There was 81% agreement between women’s report of having been breastfed and information on breastfeeding recorded when they were 2 years old. Participants were followed by record-linkage to national cancer registration, hospital admission and death databases. Cox regression yielded adjusted relative risks (RRs) and 95% confidence intervals (CI) by having been breastfed or not for eight cancer sites with > 2000 incident cases and for related conditions, where appropriate. Of the eight cancers examined here one association was highly statistically significant: an increase in colorectal cancer incidence among women who had been breastfed versus not (RR 1.18, 95% CI 1.12–1.24, n = 8651). To investigate further the findings for colorectal cancer, we studied eight other gastro-intestinal conditions, and found increased risks in women who had been breastfed versus not for benign colorectal polyps (RR 1.09, 95% CI 1.05–1.13, n = 17,677) and for appendicitis (RR 1.19, 95% CI 1.07–1.31, n = 2108). The greater risks of adult colorectal cancer, colorectal polyps and appendicitis associated with having been breastfed in infancy suggest possible long-term effects of infant feeding practices on the gastrointestinal tract. Further studies are required to clarify this novel association.
- 11 June 2019
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 34 (9) , 863-870
Open AccessAdult cancer risk in women who were breastfed as infants: large UK prospective study
There are known short-term benefits in breastfed infants versus bottle-fed infants in terms of lower risks of infection and obesity in infancy and childhood, but the long-term effect on the risk of adult cancers is unclear. In a cohort of 1 in 4 UK women born in 1935–1950 we report the incidence of adult cancers in relation to having been breastfed in infancy. In median year 2001 (interquartile range 2000–2003) 548,741 women without prior cancer reported whether they had been breastfed. There was 81% agreement between women’s report of having been breastfed and information on breastfeeding recorded when they were 2 years old. Participants were followed by record-linkage to national cancer registration, hospital admission and death databases. Cox regression yielded adjusted relative risks (RRs) and 95% confidence intervals (CI) by having been breastfed or not for eight cancer sites with > 2000 incident cases and for related conditions, where appropriate. Of the eight cancers examined here one association was highly statistically significant: an increase in colorectal cancer incidence among women who had been breastfed versus not (RR 1.18, 95% CI 1.12–1.24, n = 8651). To investigate further the findings for colorectal cancer, we studied eight other gastro-intestinal conditions, and found increased risks in women who had been breastfed versus not for benign colorectal polyps (RR 1.09, 95% CI 1.05–1.13, n = 17,677) and for appendicitis (RR 1.19, 95% CI 1.07–1.31, n = 2108). The greater risks of adult colorectal cancer, colorectal polyps and appendicitis associated with having been breastfed in infancy suggest possible long-term effects of infant feeding practices on the gastrointestinal tract. Further studies are required to clarify this novel association.
- Open Access
- 1 February 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 79, 85-86
Corrigendum to “Sex differences in common childhood infections in Taiwan” [Int. J. Infect. Dis. 75 (2018) 115–117]
- 1 February 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 79, 85-86
Open AccessCorrigendum to “Sex differences in common childhood infections in Taiwan” [Int. J. Infect. Dis. 75 (2018) 115–117]
- Open Access
- 1 October 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 75, 115-117
Sex differences in common childhood infections in Taiwan
- 1 October 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 75, 115-117
Open AccessSex differences in common childhood infections in Taiwan